Human cancer development has been linked to the tyrosine kinase receptor MET, which is encoded by the MET gene to interact with the hepatocyte growth factor (HGF) to activate downstream pathways and promote cell proliferation, migration, and angiogenesis [67]. The gene discussed is MET; the disease is cancer.